MPJE Blueprint

The MPJE Competency Statements provide a blueprint of the topics covered on the examination. A strong understanding of the Competency Statements will aid in your preparation to take the examination.

In 2015, a committee of subject matter experts reviewed the current statements and revised them to represent the most current pharmacy practice laws and regulations. The new Competency Statements will go into effect in April 2016. Both the current statements and the revised statements are posted below.

Current Competency Statements
Revised Competency Statements

Current Competency Statements

Area 1 Pharmacy Practice (Approximately 84% of Test)

  • 1.01.00 Identify the legal responsibilities of the pharmacist and other pharmacy personnel.

1.01.01 Identify the unique legal responsibilities of the pharmacist-in-charge (or equivalent), pharmacists, interns, and the owner of a pharmacy such as, the theft and/or loss of prescription drugs; the destruction/disposal of prescription drugs; and the precedence of state, federal, or local requirements.

1.01.02 Identify the qualifications, scope of duties, and conditions for practice of pharmacy technicians and all other non-pharmacist personnel, including such topics as personnel ratios and duties.

  • 1.02.00 Identify the requirements for the acquisition and distribution of pharmaceutical products, including samples.

1.02.01 Identify the requirements for ordering or obtaining pharmaceuticals, including controlled substances, from a supplier of pharmaceuticals or other sources, including the content and maintenance of records of acquisition in pedigrees.

1.02.02 Identify the requirements for distributing a pharmaceutical product, including the content and maintenance of records of distribution. This addresses who may legally possess pharmaceutical products, (including drug samples), product labeling, packaging, repackaging, compounding, and sales to practitioners.

  • 1.03.00 Identify the legal requirements that must be observed in the issuance of a prescription/drug order

1.03.01 Identify those pharmaceutical products for which a prescription/drug order is required and the limitations on their respective therapeutic uses.

1.03.02 Identify the scope of authority, scope of practice, and valid registration of all practitioners who are authorized under law to prescribe, dispense, or administer pharmaceutical products, including controlled substances. This addresses, but is not limited to federal and state registrations; methadone programs; office-based opioid treatment programs; regulations related to retired or deceased prescribers; Internet prescribing; limits on jurisdictional prescribing; and prescriber/patient relationships

1.03.03 Identify the conditions under which the pharmacist participates in the administration of pharmaceutical products, or in the management of patients’ drug therapy, which may include prescriptive authority, collaborative practice, consulting, counseling, and vaccine administration. 

1.03.04 Identify the requirements for issuing a prescription/drug order, including content and format for written; telephonic voice transmission; electronic facsimile; computer and Internet; during emergency conditions and via tamper-resistant prescription forms.

1.03.05 Identify special requirements for the issuance of controlled substance prescriptions/drug orders, including content and format for written; telephonic voice transmission; electronic facsimile; computerized and Internet; during emergency conditions; conditions for changing a prescription; time limits for dispensing initial prescriptions/drug orders; and requirements for multiple Schedule II prescription orders.

1.03.06 Identify the limits of a practitioner’s authority to authorize refills of a pharmaceutical product, including controlled substances.

  • 1.04.00 Identify the procedures necessary to properly dispense a pharmaceutical product, including controlled substances, pursuant to a prescription/drug order.

1.04.01 Identify responsibilities for determining whether prescriptions/drug orders were issued for a legitimate medical purpose and within all applicable legal restrictions, addressing such issues as corresponding responsibility; maximum quantities; and restricted distribution systems.

1.04.02 Identify the requirements for the transfer of existing prescription/drug order information from one pharmacist to another.

1.04.03 Identify the conditions under which a prescription/drug order may be filled or refilled. This includes but is not limited to emergency fills or refills; partial dispensing of controlled substances; declarations of disaster or emergency; patient identification; requirements for death with dignity; medical marijuana; and conscience/moral circumstances.

1.04.04 Identify the conditions under which prospective drug use review is conducted prior to dispensing a prescribed pharmaceutical product for appropriate patients. This includes the requirements for documentation, such as those for patient profiles.

1.04.05 Identify the conditions under which drug product selection is permitted or mandated; addressing consent of the patient and/or prescriber; passing on of cost savings; and documentation of the product dispensed.

1.04.06 Identify the requirements for the labeling of pharmaceutical products dispensed pursuant to a prescription/drug order, including such things as generic and therapeutic equivalency; formulary use; auxiliary labels; patient package inserts; Food and Drug Administration medication guides; and written drug information.

1.04.07 Identify the requirements for the appropriate packaging of pharmaceutical products dispensed pursuant to a prescription/drug order, including such things as child-resistant and customized patient medication packaging.

1.04.08 Identify the conditions under which a pharmaceutical product could not be dispensed, including conditions as in adulteration; misbranding; and dating.

1.04.09 Identify the requirements for compounding pharmaceutical products.

1.04.10 Identify the requirements for emergency kits, including such things as supplying; maintenance; access; security; and inventory

1.04.11 Identify the regulations regarding the return and/or reuse of pharmaceutical products, addressing such issues as charitable programs; cancer or other repository programs; previously dispensed; and from “will call” areas of pharmacies.

1.04.12 Identify procedures and requirements for systems or processes whereby a non-pharmacist may obtain pharmaceutical products, addressing such issues as Pyxis (vending); after hour’s access; telepharmacies; and secure automated patient drug retrieval centers.

1.04.13 Identify procedures and requirements for establishing and operating central processing and central fill pharmacies, addressing, among other things, remote order verification.

  • 1.05.00 Identify the conditions for making an offer to counsel or counseling appropriate patients, including the requirements for documentation.

1.05.01 Identify the requirements to counsel or make an offer to counsel.

1.05.02 Identify the requirements to maintain documentation of counseling.

  • 1.06.00 Identify the requirements for the distribution and/or dispensing of nonprescription pharmaceutical products, including controlled substances.

1.06.01 Identify the requirements for the labeling of nonprescription pharmaceutical products.

1.06.02 Identify the requirements for the packaging and repackaging of nonprescription pharmaceutical products.

1.06.03 Identify the requirements for the distribution and/or dispensing of poisons, restricted, nonprescription pharmaceutical products, and other restricted materials or devices including but not limited to pseudoephedrine, dextromethorphan, emergency contraception, and behind the counter products as appropriate.

  • 1.07.00 Identify the proper procedures for keeping records of information related to pharmacy practice, pharmaceutical products and patients, including requirements for protecting patient confidentiality

1.07.01Identify the requirements pertaining to controlled substance inventories.

1.07.02 Identify the content, maintenance, storage, and reporting requirements for records required in the operation of a pharmacy, including, but not limited to, prescription filing systems; computer systems and backups; and prescription monitoring programs.

1.07.03 Identify requirements for protecting patient confidentiality, including Health Insurance Portability and Accountability Act requirements.

Area 2 Licensure, Registration, Certification, and Operational Requirements (Approximately 13% of Test)

  • 2.01.00  Identify the qualifications, application procedure, necessary examinations, and internship requirements for licensure, registration, or certification of individuals engaged in the storage, distribution, and/or dispensing of pharmaceutical products (prescription and nonprescription).

2.01.01 Identify the requirements for special or restricted licenses, registrations, authorizations, or certificates for pharmacists, pharmacist preceptors, pharmacy interns, pharmacy technicians, controlled substance registrants, and under specialty pharmacist licenses (nuclear, consultant, etc).

2.01.02 Identify the standards of practice for the practice of pharmacy, including, but not limited to quality assurance programs, including peer review; changing dosage forms; therapeutic substitution; error reporting; public health reporting requirements, such as notification of potential terrorist event, physical abuse, and treatment for tuberculosis; and issues of conscience and maintaining competency.

2.01.03 Identify notification requirements pertaining to their license to practice pharmacy.

2.01.04 Identify the requirements for the renewal or reinstatement of an individual’s licensure, registration, or certification.

2.01.05 Identify the reasons for classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted individual.

2.01.06 Identify the requirements for reporting to, and participating in, programs addressing the inability of an individual licensed, registered, or certified by the board to engage in the practice of pharmacy with reasonable skill and safety, by reason of impairment caused by the use of alcohol, drugs, chemicals, or other materials or mental, physical, or psychological conditions. 

  • 2.02.00 Identify the requirements and application procedure for the registration, licensure, certification, or permitting of a practice setting or business entity

2.02.01 Identify the requirements for registration, license, certification, or permitting of a practice setting, including but not limited to, in-state pharmacies; out-of-state pharmacies; specialty pharmacies; controlled substance registrants; wholesalers; distributors; manufacturers/repackagers; computer services providers; and Internet pharmacies.

2.02.02 Identify the operational and notification requirements for changes to the facility or changes in the application for licensure, registration, certification, or permit of a practice setting such as in remodeling; renaming; change of ownership; moving; and closing.

2.02.03 Identify the requirements for an inspection of a licensed, registered, certified, or permitted practice setting.

2.02.04 Identify the requirements for the renewal or reinstatement of a license, registration, certificate, or permit of a practice setting.

2.02.05 Identify the reasons for classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted practice setting.

  • 2.03.00 Identify the operational requirements for a registered, licensed, certified, or permitted practice setting.

2.03.01 Identify the requirements for the operation of a pharmacy or practice setting that are not directly related to the dispensing of pharmaceutical products. This includes, but is not limited to, issues related to space; equipment; advertising and signage; security, including temporary absences of the pharmacist; policies and procedures; libraries; and the display of licenses.

2.03.02 Identify the requirements for the possession, storage, and handling of pharmaceutical products, including controlled substances. This includes, but is not limited to, investigational new drugs; repackaged or resold drugs; sample pharmaceuticals; recalls; and outdated pharmaceutical products.

2.03.03 Identify the requirements for delivery of pharmaceutical products, including controlled substances. This includes, but is not limited to, issues related to identification of the person accepting delivery of a drug; use of the mail; contract delivery; use of couriers; use of pharmacy employees; use of kiosks, secure mail boxes, and script centers; use of vacuum tubes; and use of drive-up windows.

Area 3 Regulatory Structure and Terms (Approximately 3% of Test)

  • 3.01.00 Identify the purpose of, and the terms and conditions found in, the laws and rules that regulate or affect the manufacture, storage, distribution, and dispensing of pharmaceutical products (prescription and nonprescription), including controlled substances. 

This includes such things as the Food, Drug, and Cosmetic Act(s) and Regulations; the Controlled Substances Act(s) and Regulations; OBRA 90’s Title IV Requirements; Practice Acts and Rules; other statutes and regulations, including but not limited to, dispensing of methadone, child-resistant packaging, tamper-resistant packaging, drug paraphernalia, drug samples, pharmacist responsibilities in Medicare-certified skilled-nursing facilities; National Drug Code numbers; and schedules of controlled substances.

  • 3.02.00 Identify the authority, responsibilities, and operation of the agencies or entities that enforce the laws and rules that regulate or affect the manufacture, storage, distribution, and dispensing of pharmaceutical products (prescription and nonprescription), including controlled substances. 

Revised Competency Statements

Area 1 – Pharmacy Practice (83%)

  • 1.1 Legal responsibilities of the pharmacist and other pharmacy personnel
  • 1.1.1 Unique legal responsibilities of the pharmacist-in-charge (or equivalent), pharmacists, interns, and pharmacy owners
    • Responsibilities for inventory, loss and/or theft of prescription drugs, the destruction/disposal of prescription drugs and the precedence of Local, State, or Federal requirements
  • 1.1.2 Qualifications, scope of duties, and conditions for practice relating to pharmacy technicians and all other non-pharmacist personnel
    • Personnel ratios, duties, tasks, roles, and functions of non-pharmacist personnel
  • 1.2 Requirements for the acquisition and distribution of pharmaceutical products, including samples
  • 1.2.1 Requirements and record keeping in relation to the ordering, acquiring, and maintenance of all pharmaceutical products and bulk drug substances/excipients
    • Legitimate suppliers, pedigrees and the maintenance of acquisition records​
  • 1.2.2 Requirements for distributing pharmaceutical products and preparations, including the content and maintenance of distribution records
    • Legal possession of pharmaceutical products (including drug samples), labeling, packaging, repackaging, compounding, and sales to practitioners
  • 1.3 Legal requirements that must be observed in the issuance of a prescription/drug order
  • 1.3.1 Prescription/order requirements for pharmaceutical products and the limitations on their respective therapeutic uses
    • Products, preparations, their uses and limitations applicable to all prescribed orders for both human and veterinary uses
  • 1.3.2 Scope of authority, scope of practice, and valid registration of all practitioners who are authorized under law to prescribe, dispense, or administer pharmaceutical products, including controlled substances
    • Federal and State registrations, methadone programs, office-based opioid treatment programs, regulations related to retired or deceased prescribers, Internet prescribing, limits on jurisdictional prescribing
  • 1.3.3 Conditions under which the pharmacist participates in the administration of pharmaceutical products, or in the management of patients' drug therapy
    • Prescriptive authority, collaborative practice, consulting, counseling, medication administration (including immunization, vaccines), ordering labs, medication therapy management, and disease state management
  • 1.3.4 Requirements for issuing a prescription/order
    • Content and format for written, telephonic voice transmission, electronic facsimile, computer and Internet, during emergency conditions, and tamper-resistant prescription forms.
  • 1.3.5 Requirements for the issuance of controlled substance prescriptions/orders
    • Content and format for written, telephonic voice transmission, electronic facsimile, computerized and Internet, during emergency conditions, conditions for changing a prescription, time limits for dispensing initial prescriptions/drug orders, and requirements for multiple Schedule II orders
  • 1.3.6 Limits of a practitioner’s authority to authorize refills of a pharmaceutical product, including controlled substances
  • 1.4 Procedures necessary to properly dispense a pharmaceutical product, including controlled substances, pursuant to a prescription/drug order
  • 1.4.1 Responsibilities for determining whether prescriptions/orders were issued for a legitimate medical purpose and within all applicable legal restrictions
    • Corresponding responsibility, maximum quantities, restricted distribution systems, red flags/automated alerts, controlled substances, valid patient / prescriber relationship, and due diligence to ensure validity of the order​
  • 1.4.2 Requirements for the transfer of existing prescription/order information from one pharmacist to another
  • 1.4.3 Conditions under which a prescription/order may be filled or refilled
    • Emergency fills or refills, partial dispensing of a controlled substance, disaster or emergency protocol, patient identification, requirement for death with dignity, medical marijuana, and conscience /moral circumstances
  • 1.4.4 Conditions under which prospective drug use review is conducted prior to dispensing
    • Patient specific therapy and requirements for patient specific documentation
  • 1.4.5 Conditions under which product selection is permitted or mandated
    • Consent of the patient and/or prescriber, passing-on of cost savings, and appropriate documentation
  • 1.4.6 Requirements for the labeling of pharmaceutical products and preparations dispensed pursuant to a prescription/order
    • Generic and therapeutic equivalency, formulary use, auxiliary labels, patient package inserts, FDA medication guides, and written drug information
  • 1.4.7 Packaging requirements of pharmaceutical products, preparations, and devices to be dispensed pursuant to a prescription/order
    • Child-resistant and customized patient medication packaging
  • 1.4.8 Conditions under which a pharmaceutical product, preparation, or device may not be dispensed
    • Adulteration, misbranding, and dating
  • 1.4.9 Requirements for compounding pharmaceutical products
    • Environmental controls, release checks and testing, beyond use date (BUD), initial and ongoing training
  • 1.4.10 Requirements for emergency kits
    • Supplying, maintenance, access, security, and inventory
  • 1.4.11 Conditions regarding the return and/or reuse of pharmaceutical products, preparations, bulk drug substances/excipients, and devices
    • Charitable programs, cancer or other repository programs, previously dispensed, and from ""will call"" areas of pharmacies
  • 1.4.12 Procedures and requirements for systems or processes whereby a non-pharmacist may obtain pharmaceutical products, preparations, bulk drug substances/excipients, and devices
    • Pyxis (vending), after hour’s access, telepharmacies, and secure automated patient drug retrieval centers
  • 1.4.13 Procedures and requirements for establishing and operating central processing and central fill pharmacies
    • Remote order verification
  • 1.4.14 Requirements for reporting to PMP, accessing information in a PMP and the maintenance of security and confidentiality of information accessed in PMPs
  • 1.4.15 Requirements when informed consent must be obtained from the patient and/or a duty to warn must be executed
    • Collaborative practice and investigational drug therapy
  • 1.5 Conditions for making an offer to counsel or counseling appropriate patients, including the requirements for documentation
  • 1.5.1 Requirements to counsel or to make an offer to counsel
  • 1.5.2 Required documentation necessary for counseling
  • 1.6 Requirements for the distribution and/or dispensing of non-prescription pharmaceutical products, including controlled substances
  • 1.6.1 Requirements for the labeling of non-prescription pharmaceutical products and devices
  • 1.6.2 Requirements for the packaging and repackaging of non-prescription pharmaceutical products and devices
  • 1.6.3 Requirements for the distribution and/or dispensing of poisons, restricted, non-prescription pharmaceutical products, and other restricted materials or devices
    • Pseudoephedrine, dextromethorphan, emergency contraception, and behind the counter products as appropriate
  • 1.7 Procedures for keeping records of information related to pharmacy practice, pharmaceutical products and patients, including requirements for protecting patient confidentiality
  • 1.7.1 Requirements pertaining to controlled substance inventories
  • 1.7.2 Content, maintenance, storage, and reporting requirements for records required in the operation of a pharmacy​
    • Prescription filing systems, computer systems and backups, and prescription monitoring programs
  • 1.7.3 Requirements for protecting patient confidentiality and confidential health records
    • HIPAA requirements and conditions for access and use of information
  • 1.8 Requirements for handling hazardous materials such as described in USP <800>
  • 1.8.1 Requirements for appropriate disposal of hazardous materials
  • 1.8.2 Requirements for training regarding hazardous materials​
    • Reverse distributors, quarantine procedures, comprehensive safety programs, Material Safety Data Sheets
  • 1.8.3 Environmental controls addressing the proper storage, handling, and disposal of hazardous materials
    • Ventilation controls, personal protective equipment, work practices, and reporting
  • 1.8.4 Methods for the compounding, dispensing and administration of hazardous materials
    • All hazardous materials including sterile and non-sterile compounding

Area 2 – Licensure, Registration, Certification, and Operational Requirements (15%)

  • 2.1 Qualifications, application procedure, necessary examinations, and internship for licensure, registration, or certification of individuals engaged in the storage, distribution, and/or dispensing of pharmaceutical products (prescription and non-prescription)
  • 2.1.1 Requirements for special or restricted licenses, registration, authorization, or certificates
    • Pharmacists, pharmacist preceptors, pharmacy interns, pharmacy technicians, controlled substance registrants, and under specialty pharmacist licenses (Nuclear, Consultant etc.)
  • 2.1.2 Standards of practice related to the practice of pharmacy
    • Quality assurance programs (including peer review), changing dosage forms, therapeutic substitution, error reporting, public health reporting requirements (such as notification of potential terrorist event, physical abuse, and treatment for tuberculosis), and issues of conscience and maintaining competency
  • 2.1.3 Requirements for classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted individual
  • 2.1.4 Requirements for reporting to, and participating in, programs addressing the inability of an individual licensed, registered, or certified by the Board to engage in the practice of pharmacy with reasonable skill and safety
    • Impairment caused by the use of alcohol, drugs, chemicals, or other materials, or mental, physical, or psychological conditions
  • 2.2 Requirements and application procedure for the registration, licensure, certification, or permitting of a practice setting or business entity
  • 2.2.1 Requirements for registration, license, certification, or permitting of a practice setting
    • In-state pharmacies, out-of-state pharmacies, specialty pharmacies, controlled substance registrants, wholesalers, distributors, manufacturers/repackagers, computer services providers, and internet pharmacies
  • 2.2.2 Requirements for an inspection of a licensed, registered, certified, or permitted practice setting
  • 2.2.3 Requirements for the renewal or reinstatement of a license, registration, certificate, or permit of a practice setting
  • 2.2.4 Classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted practice setting
  • 2.3 Operational requirements for a registered, licensed, certified, or permitted practice setting
  • 2.3.1 Requirements for the operation of a pharmacy or practice setting that is not directly related to the dispensing of pharmaceutical products
    • Issues related to space, equipment, advertising and signage, security (including temporary absences of the pharmacist), policies and procedures, libraries and references (including veterinary), and the display of licenses
  • 2.3.2 Requirements for the possession, storage, and handling of pharmaceutical products, preparations, bulk drug substances/excipients, and devices, including controlled substances
    • Investigational new drugs, repackaged or resold drugs, sample pharmaceuticals, recalls, and outdated pharmaceutical products
  • 2.3.3 Requirements for delivery of pharmaceutical products, preparations, bulk drug substances/excipients, and devices, including controlled substances
    • Issues related to identification of the person accepting delivery of a drug, use of the mail, contract delivery, use of couriers, use of pharmacy employees, use of kiosks, secure mail boxes, script centers, use of vacuum tubes, and use of drive-up windows

Area 3 – General Regulatory Processes (2%)

  • 3.1 Application of regulations
  • 3.1.1 Laws and rules that regulate or affect the manufacture, storage, distribution, and dispensing of pharmaceutical products, preparations, bulk drug substances/excipients, and devices, (prescription and non-prescription), including controlled substances
    • Food, Drug, and Cosmetic Act(s) and Regulations, the Controlled Substances Act(s) and Regulations, OBRA 90's Title IV Requirements, Practice Acts and Rules, other statutes and regulations, including but not limited to, dispensing of methadone, child-resistant packaging, tamper resistant packaging, drug paraphernalia, drug samples, pharmacist responsibilities in Medicare-certified skilled-nursing facilities, NDC numbers, and schedules of controlled substances